BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9029153)

  • 1. Cdk2-dependent phosphorylation of Id2 modulates activity of E2A-related transcription factors.
    Hara E; Hall M; Peters G
    EMBO J; 1997 Jan; 16(2):332-42. PubMed ID: 9029153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Id3 cell cycle function by Cdk-2-dependent phosphorylation.
    Deed RW; Hara E; Atherton GT; Peters G; Norton JD
    Mol Cell Biol; 1997 Dec; 17(12):6815-21. PubMed ID: 9372912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of the helix-loop-helix factor Id2 to regulation of vascular smooth muscle cell proliferation.
    Matsumura ME; Lobe DR; McNamara CA
    J Biol Chem; 2002 Mar; 277(9):7293-7. PubMed ID: 11706002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of E2F-1 by cyclin A-cdk2.
    Kitagawa M; Higashi H; Suzuki-Takahashi I; Segawa K; Hanks SK; Taya Y; Nishimura S; Okuyama A
    Oncogene; 1995 Jan; 10(2):229-36. PubMed ID: 7838523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation by G1-specific cdk-cyclin complexes activates the nucleolar transcription factor UBF.
    Voit R; Hoffmann M; Grummt I
    EMBO J; 1999 Apr; 18(7):1891-9. PubMed ID: 10202152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells.
    Morris TA; DeLorenzo RJ; Tombes RM
    Exp Cell Res; 1998 May; 240(2):218-27. PubMed ID: 9596994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation and activation of B-Myb by cyclin A-Cdk2.
    Ziebold U; Bartsch O; Marais R; Ferrari S; Klempnauer KH
    Curr Biol; 1997 Apr; 7(4):253-60. PubMed ID: 9094315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression.
    Hall C; Nelson DM; Ye X; Baker K; DeCaprio JA; Seeholzer S; Lipinski M; Adams PD
    Mol Cell Biol; 2001 Mar; 21(5):1854-65. PubMed ID: 11238922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
    Morris L; Allen KE; La Thangue NB
    Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin E/Cdk2 activity is controlled by different mechanisms in the G0 and G1 phases of the cell cycle.
    Bresnahan WA; Boldogh I; Ma T; Albrecht T; Thompson EA
    Cell Growth Differ; 1996 Oct; 7(10):1283-90. PubMed ID: 8891332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cell-cycle regulated transcription factor B-Myb is phosphorylated by cyclin A/Cdk2 at sites that enhance its transactivation properties.
    Saville MK; Watson RJ
    Oncogene; 1998 Nov; 17(21):2679-89. PubMed ID: 9840932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for a p21-E2F interaction during senescence arrest of normal human fibroblasts.
    Afshari CA; Nichols MA; Xiong Y; Mudryj M
    Cell Growth Differ; 1996 Aug; 7(8):979-88. PubMed ID: 8853893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints.
    Xie G; Habbersett RC; Jia Y; Peterson SR; Lehnert BE; Bradbury EM; D'Anna JA
    Oncogene; 1998 Feb; 16(6):721-36. PubMed ID: 9488036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective repression of growth-regulating cdk2, cyclin E and E2F1 genes in human cell senescence.
    Kanazawa S; Fujiwara Y; Mizuno K
    Kobe J Med Sci; 1994 Dec; 40(5-6):165-74. PubMed ID: 7542356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-directed mutant p21 proteins defective in both inhibition of E2F-regulated transcription and disruption of E2F-p130-cyclin-cdk2 complexes.
    Robles SJ; Shiyanov P; Aristodemo GT; Raychaudhuri P; Adami GR
    DNA Cell Biol; 1998 Jan; 17(1):9-18. PubMed ID: 9468218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclin D2 activates Cdk2 in preference to Cdk4 in human breast epithelial cells.
    Sweeney KJ; Sarcevic B; Sutherland RL; Musgrove EA
    Oncogene; 1997 Mar; 14(11):1329-40. PubMed ID: 9178893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of the actin cytoskeleton leads to inhibition of mitogen-induced cyclin E expression, Cdk2 phosphorylation, and nuclear accumulation of the retinoblastoma protein-related p107 protein.
    Reshetnikova G; Barkan R; Popov B; Nikolsky N; Chang LS
    Exp Cell Res; 2000 Aug; 259(1):35-53. PubMed ID: 10942577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and subcellular localization of CDK2 and cdc2 kinases and their common partner cyclin A in thyroid epithelial cells: comparison of cyclic AMP-dependent and -independent cell cycles.
    Baptist M; Lamy F; Gannon J; Hunt T; Dumont JE; Roger PP
    J Cell Physiol; 1996 Feb; 166(2):256-73. PubMed ID: 8591985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of cell cycle control by deregulation of cyclin-dependent kinase 2 kinase activity in Evi-1 transformed fibroblasts.
    Kilbey A; Stephens V; Bartholomew C
    Cell Growth Differ; 1999 Sep; 10(9):601-10. PubMed ID: 10511310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.